According to GlobalData, STEALTH 360 is one of 26 product lines sold in the US atherectomy devices market; these product lines are sold by 8 different manufacturers. The average selling price for STEALTH 360 decreased in hospitals, increased in health systems, and decreased outside of hospital facilities in 2022. The price of the STEALTH 360 device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Cardiovascular Systems apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Cardiovascular Systems overview

Cardiovascular Systems Inc (CSI), a subsidiary of Abbott Laboratories, is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company’s products include peripheral orbital atherectomy systems, coronary orbital atherectomy systems, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors in the US to hospitals and clinics. CSI is headquartered in St. Paul, Minnesota, the US.

For a complete picture of STEALTH 360, Atherectomy Devices pricing in the US, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.